Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-7,045,560 |
Antifouling coating An antifouling coating which comprises a varnish comprised of a metal-containing acrylic resin having, in a side chain thereof, at least one group represented... |
| US-7,045,559 |
Electrically conductive adhesive hydrogels with solubilizer A composition providing electrically conductive adhesive hydrogels suitable for use as skin contact adhesives and, particularly, suitable for use as an... |
| US-7,045,558 |
Method of making a high refractive index optical management coating and
the coating A radiation curable composition comprises a heterocyclic acrylate or heterocyclic methacrylate. The composition is curable to make an optical management article... |
| US-7,045,557 |
Light-degradable material for producing disposable medical appliances The present invention relates to a light-degradable material for producing disposable medical appliances having main components of polypropylene resin and... |
| US-7,045,556 |
Polyolefin foams made with isopentane-based blowing agents A blowing agent blend for making polyolefin foams comprising isopentane and at least one co-blowing agent. The co-blowing agent is either a physical co-blowing... |
| US-7,045,555 |
Regenerated resin composition A regenerated resin composition comprising (I) a molded article pulverized material (Component A) that satisfies conditions (1) that the molded article... |
| US-7,045,554 |
Method for improved Fischer-Tropsch catalyst stability and higher stable
syngas conversion The present invention is generally related towards methods for preparing and using a more stable synthesis catalysts. In particular, the present invention is... |
| US-7,045,553 |
Hydrocarbon synthesis process using pressure swing reforming The invention provides a method for producing liquid hydrocarbons by first generating in a pressure swing reformer a synthesis gas stream having a mole ratio of... |
| US-7,045,552 |
Pharmaceutical composition for improved administration of HIV gp41-derived
peptides, and its use in therapy Provided is a pharmaceutical composition comprising a solution comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture... |
| US-7,045,551 |
1-aryl-2-hydroxyethyl amides as potassium channel openers The present invention provides novel aryl hydroxyethyl amides and related derivatives having the general Formula I ##STR00001## wherein R.sup.1, R.sup.2,... |
| US-7,045,550 |
Polyamines and analogs for protecting cells during cancer chemotherapy and
radiotherapy Polyamine effectors are administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy, such as alopecia,... |
| US-7,045,549 |
Treatment of symptoms associated with irritable bowel syndrome Methods are provided for use in treating humans suffering from irritable bowel syndrome. In the subject methods, an effective amount of a nerve-acting agent,... |
| US-7,045,548 |
Methods of inactivating viruses A method of inactivating viruses comprises contacting the virus with a virucidally effective amount of a composition consisting essentially of a C1 to C3... |
| US-7,045,547 |
Acyl-CoA dehydrogenase allenic inhibitors Compounds of formula I ##STR00001## wherein A is R.sup.3, OR.sup.3, SR.sup.3, and NR.sup.3R.sup.4; and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined.... |
| US-7,045,546 |
Stabilized derivatives of ascorbic acid-3-phosphate Novel derivatives of ascorbic acid and compositions comprising them are provided. The novel derivatives are of the following general formula (I): where R1 is a... |
| US-7,045,545 |
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.4', R.sup.5, R.sup.5', and... |
| US-7,045,544 |
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of
cardiovascular diseases The invention relates to compounds of formula (I), to a method for the production thereof, and to the use of the same as pharmaceuticals for the treatment of... |
| US-7,045,543 |
Covalent conjugates of biologically-active compounds with amino acids and
amino acid derivatives for targeting... This invention herein describes a method of facilitating the entry of drugs into cells and tissues at physiologically protected sites at pharmacokinetically... |
| US-7,045,542 |
Low-temperature-stable preservatives A liquid, cold-temperature-stabilized preservative is based on carbendazim or a salt thereof, which includes, as low-temperature stabilizer, at least one... |
| US-7,045,541 |
Compounds for the treatment of metabolic disorders Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia,... |
| US-7,045,540 |
Selective estrogen receptor modulators The present invention provides, inter alia, triphenylethylene derivatives, such as, 5-{2-[4-(1,2-Diphenyl-but-1-enyl)-phenyl]-vinyl}-1H-tetrazole, as selective... |
| US-7,045,539 |
Therapeutic benzoxazole compounds Compounds of the formula (I) for use as an estrogen receptor-.beta.-selective ligand are described wherein: X is O or S; and R.sup.1, R.sup.3 R.sup.6 are as... |
| US-7,045,538 |
Compounds capable of activating cholinergic receptors The present invention generally relates to nicotinic compounds, in the form of aryl substituted olefinic compounds, as well as pro-drug, N-oxide, metabolite and... |
| US-7,045,537 |
Protein structures and protein fibres This invention relates to protein fiber formation and in particular to methods of producing protein fibers to form a protein structure comprising a plurality of... |
| US-7,045,536 |
Compound having anti-viral activity The present invention discloses an organic ionic compound having anti-viral activity and the method for antagonizing virus in vitro by putting the compounds in... |
| US-7,045,535 |
Compounds useful for inhibiting paramyxovirus neuraminidase Certain cyclic compounds are presented as well as their use for inhibiting paramyxovirus neuraminidase. The compounds are represented by the following formulas: ... |
| US-7,045,534 |
Methods of reducing angiogenesis The present invention provides methods of reducing angiogenesis in an individual. The methods generally involve administering to the individual an effective... |
| US-7,045,533 |
Naphthalene derivatives The present invention relates to novel naphthalene derivatives of formula (I), wherein R.sup.1, R.sup.2, R.sup.3 and X are as defined in the description, and... |
| US-7,045,532 |
ACE-2 modulating compounds and methods of use thereof ACE-2 inhibitors for the treatment of body weight and related disorders are disclosed. ACE-2 inhibitors include peptides and small molecules. Examples of small... |
| US-7,045,531 |
Composition comprising a metal chelator and a method of treating
amyloidosis by administering the metal chelator The invention relates to the identification of pharmacological agents to be used in the treatment of Alzheimer's disease and related pathological conditions.... |
| US-7,045,530 |
Spirocyclic quinuclidinic ether derivatives Compounds of formula (I) ##STR00001## wherein n1 is 0, 1, or 2; n2 is 0, 1, or 2; X is a bond, O, S, or NR.sub.1; and Ar.sub.1 is a 5-membered aromatic ring,... |
| US-7,045,529 |
Imidazopyrimidinyl and imidazopyri dinyl derivatives Provided herein are compounds of the formula (I): ##STR00001## as well as stereoisomers and pharmaceutically acceptable salts thereof. Such compounds are,... |
| US-7,045,528 |
Benzofused heterozryl amide derivatives of thienopyridines useful as
therapeutic agents, pharmaceutical... The invention relates to compounds represented by the formula I ##STR00001## and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or... |
| US-7,045,527 |
Piperidine derivatives Compounds, compositions and methods are provided that are useful in the treatment or prevention of conditions or disorders associated with a neuropeptide... |
| US-7,045,526 |
Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation,
their use and pharmaceutical preparations... The present invention relates to compounds of formula I: ##STR00001## wherein R.sup.1, R.sup.2, and R.sup.3 have the meanings indicated in the specification,... |
| US-7,045,525 |
Use of (R)-peniciclovir triphosphate for the manufacture of a medicament
for the treatment of viral diseases A method of treatment of: i) HIV-1 infections in mammals, including humans; or ii) HBV infections in mammals, including humans; which method comprises the... |
| US-7,045,524 |
Pleuromutilin derivatives with antimicrobial activity Pleuromutilin compounds of the formula: ##STR00001## are of use in anti-bacterial therapy. |
| US-7,045,523 |
Combination comprising
N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-p-
... A method of treating BCR-ABL positive leukemia in a warm-blooded animal comprising administering the combination of ... |
| US-7,045,522 |
8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field The present invention relates to novel 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives which are found to be cholinergic ligands at the nicotinic Acetyl... |
| US-7,045,521 |
Cyclic derivatives as modulators of chemokine receptor activity The present application describes modulators of MCP-1 of formula (I): ##STR00001## or pharmaceutically acceptable salt forms thereof, useful for the prevention... |
| US-7,045,520 |
Opioid receptor active compounds The invention provides compounds of formula I: ##STR00001## wherein R.sup.1 to R.sup.4 and n have any of the meanings defined in the specification and their... |
| US-7,045,519 |
Inhibitors of glycogen synthase kinase 3 New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of... |
| US-7,045,518 |
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease
inhibitors Selected sulfonylalkanoylamino hydroxyethylamine sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV... |
| US-7,045,517 |
Triazine compounds This invention relates to triazine compounds of formula (I): ##STR00001## R.sub.1 is , aryl, ##STR00002## or heteroaryl; each of R.sub.2, R.sub.4, and... |
| US-7,045,516 |
Benzoxazole derivatives and drugs containing the same as the active
ingredient A compound represented by the following general formula (1): ##STR00001## wherein R.sup.1 represents a halogen atom, R.sup.2 represents hydrogen atom or a lower... |
| US-7,045,515 |
.beta.-lactam compounds process for reproducing the same and serum
cholesterol-lowering agents containing the same Novel .beta.-lactam compounds represented by the following formula (I) or pharmaceutically acceptable salts thereof which are useful as serum ... |
| US-7,045,514 |
Therapeutic heterocyclic compounds Provided herein is a compound having the formula (I): ##STR00001## Wherein said compounds are useful for the treatment of psychiatric disorders including but... |
| US-7,045,513 |
DHEA composition and method Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic... |
| US-7,045,512 |
Fungicidal phenoxyphenylhydrazine derivatives A fungicidally active compound of the formula: a) ##STR00001## wherein Q is --NY--NH--, --N.dbd.N--, or ##STR00002## X is oxygen, sulfur, sulfoxide, or... |
| US-7,045,511 |
Fosinopril formulation A pharmaceutical formulation is provided comprising fosinopril which is the prodrug of an angiotensin converting enzyme (ACE) inhibitor, fosinoprilat. The... |
Copyright 2008−2012 Patents.com
